AF
CBAY

Allworth Financial’s Cymabay Therapeutics CBAY Stock Holding History

Allworth Financial’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-132
Closed -$3.12K – 3705
2023
Q4 		$3.12K Buy
132
+124
+1,550% +$2.21K ﹤0.01% 2473
2023
Q3 		$120 Buy
+8
New +$106 ﹤0.01% 3318

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Allworth Financial's CBAY Position: Q1 2024 in Review

Allworth Financial sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 132 shares — an estimated $3.12K sold.

Allworth Financial first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $3.12K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Allworth Financial reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Allworth Financial sold 132 Cymabay Therapeutics shares in Q1 2024, an estimated $3.12K.
  • Allworth Financial first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
  • Allworth Financial's Cymabay Therapeutics position peaked at $3.12K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Allworth Financial's 13F filing for Q1 2024, filed 25 Apr 2024.